Trials / Recruiting
RecruitingNCT07028489
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (estimated)
- Sponsor
- N-Power Medicine · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to build a prospective cohort in patients with locally advanced or metastatic NSCLC with common EGFR mutations. In NPM-002, there will be standardized data collection at baseline, on-treatment and at discontinuation of therapy. Patients who enroll prior to initiation of osimertinib treatment (\~30%) will undergo imaging with standardized intervals.
Conditions
Timeline
- Start date
- 2025-06-05
- Primary completion
- 2028-12-01
- Completion
- 2029-04-01
- First posted
- 2025-06-19
- Last updated
- 2026-03-03
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT07028489. Inclusion in this directory is not an endorsement.